US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist
  • 1.900
  • +0.120+6.74%
Close Nov 22 16:00 ET
  • 1.960
  • +0.060+3.16%
Post 20:02 ET
84.67MMarket Cap-1250P/E (TTM)

About Werewolf Therapeutics Company

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.

Company Profile

SymbolHOWL
Company NameWerewolf Therapeutics
Listing DateApr 30, 2021
Issue Price16.00
Founded2017
CEODr. Daniel J. Hicklin,, PhD
MarketNASDAQ
Employees47
Fiscal Year Ends12-31
Address200 Talcott Avenue,2nd floor
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-952-0555
Websitehttp://www.werewolftx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Daniel J. Hicklin,, PhD
  • Director, President and Chief Executive Officer
  • 1.37M
  • Timothy W. Trost
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 815.59K
  • Dr. Randi Isaacs, M.D.
  • Chief Medical Officer
  • 855.77K
  • Dr. Chulani Karunatilake, PhD
  • Chief Technology Officer
  • --
  • Ellen Lubman, M.B.A.
  • Chief Business Officer
  • --
  • Dr. Luke B. Evnin,PhD
  • Chairman of the Board
  • 104.03K
  • Dr. Briggs W. Morrison, M.D.
  • Director
  • 62.32K
  • Dr. Michael B. Atkins, M.D.
  • Director
  • --
  • Dr. Meeta Chatterjee, PhD
  • Independent Director
  • 65.36K
  • Dr. Derek DiRocco, PhD
  • Independent Director
  • 72.53K
  • Michael A. Sherman
  • Independent Director
  • 78.66K
  • Dr. Alon Lazarus, PhD
  • Independent Director
  • 78.53K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data